Achillion Pharmaceuticals Accounts Receivable:
0.589M for March 31, 2013Achillion Pharmaceuticals Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.589M |
| Dec. 31, 2012 | 0.277M |
| Sept. 30, 2012 | 0.463M |
| June 30, 2012 | 0.426M |
| March 31, 2012 | 0.017M |
| Dec. 31, 2011 | 0.103M |
| Sept. 30, 2011 | 0.093M |
| June 30, 2011 | 0.363M |
| March 31, 2011 | 0.093M |
| Dec. 31, 2010 | 0.246M |
| Sept. 30, 2010 | 0.091M |
| June 30, 2010 | 0.187M |
| March 31, 2010 | 0.083M |
| Dec. 31, 2009 | 0.065M |
| Sept. 30, 2009 |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
ACHN Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Acorda Therapeutics | 23.29M |
| Discovery Laboratories | |
| Exelixis |
ACHN Accounts Receivable Rankings
| Overall |
56th percentile 3460 of 8002 |
| Sector |
40th percentile 388 of 650 in Healthcare |
| Industry |
59th percentile 95 of 237 in Biotechnology |
ACHN Accounts Receivable Range, Past 5 Years
| Minimum | 0.00 | Dec 2008 |
| Maximum | 0.5890M | Mar 2013 |
| Average | 0.2166M |
